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Background: Activation of peroxisome proliferator activated receptor gamma (PPAR γ) in the alveolar macrophages
(AM) by selective synthetic PPAR γ ligands, improves the ability of the cells to resolve inflammation. In birds,
respiratory macrophages are known as free avian respiratory macrophages (FARM) and show distinct functional
differences from AM. The effects of treating FARM with PPAR γ ligands are unclear.
Methods: FARM were harvested by lavage of chicken respiratory tract and their morphology assessed at
microscopic level. The effects of PPAR γ agonists on the FARM in vitro viability, phagocytic capacity and
proinflammatory cytokine (TNF-α) production were assessed.
Results: FARM had eccentric nucleus and plasma membrane ruffled with filopodial extensions. Ultrastructurally,
numerous vesicular bodies presumed to be lysosomes were present. FARM treated with troglitazone, a selective
PPAR γ agonist, had similar in vitro viability with untreated FARM. However, treated FARM co-cultured with
polystyrene particles, internalized more particles with a mean volume density of 41 % compared to that of
untreated FARM of 21 %. Further, treated FARM significantly decreased LPS-induced TNF-α production in a dose
dependent manner.
Conclusion: Results from this study show that PPAR γ synthetic ligands enhance phagocytic ability of FARM.
Further the ligands attenuate production of proinflammatory cytokines in the FARM, suggesting potential
therapeutic application of PPAR γ ligands in the management of respiratory inflammatory disorders in the poultry
industry.
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Alveolar macrophages (AM) in mammals constitute first
line of pulmonary defense where they expunge deposited
foreign particles and kill pathogens that land on the vast
and thin gas-blood tissue barrier [1]. Following infec-
tions, activated AM produce proinflammatory cytokines
and other mediators of inflammation that serve to
localize and remove injurious stimuli [2]. However, pro-
longed inflammation is maladaptive and is characterized* Correspondence: patmbuvi@gmail.com
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augmenting respiratory epithelial tissue damage [3].
Peroxisome proliferator activated receptors (PPAR) are
ligand activated transcription factors and three isoforms,
PPAR α, PPAR δ and PPAR γ have been described [4].
The PPAR show distinct tissue distribution [5, 6] with
PPAR γ being predominantly expressed in adipose tissue
where it plays an important role in glucose metabolism
and adipogenesis [7]. Expression of PPAR γ protein has
also been demonstrated in monocytes and macrophages
[8]. Thiazolidinediones are selective synthetic PPAR γ
agonists [9, 10] which improve the ability of AM to re-
store alveolar architecture through non phlogisticis distributed under the terms of the Creative Commons Attribution 4.0
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Fig. 1 A Photomicrograph showing epithelial cells (E) with cilia (arrows)
and a collection of FARM (m) recovered by lavage of chicken respiratory
system. The photomicrograph was developed from semithin (1 μm)
section cut from a processed block of epoxy resin embedded cell
suspension. (×400)
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[11, 12]. Chicken peroxisome proliferator activated re-
ceptor gamma (chPPAR γ) is structurally different from
the mammalian PPAR γ suggesting different functional
roles [13, 14].
Respiratory disease conditions, partly characterized by
chronic inflammation of the respiratory epithelia, cause
immense economic losses in the poultry industry [15,
16]. Despite the losses, relatively little is known about
the avian pulmonary cellular defense mechanisms [17,
18]. In birds, respiratory macrophages are referred to as
free avian respiratory macrophages (FARM) [19, 20] and
dearth of the cells in the lung air sac system has been
purported to foreordain a weak innate immunity thus
predisposing birds to respiratory inflictions [21–23].
However, FARM exhibit a significantly higher phagocytic
ability than AM [24] and mobilization of the cells in the
avian respiratory system does not occur after intravenous
application of lipopolysaccharide, incomplete freunds adju-
vant or glucan, compounds known to induce migration of
AM from the lung interstitium into the alveolar space [25].
The effects of PPAR γ agonists on FARM are unknown.
The aim of this study was, therefore, to determine:
(i) The effect of selective synthetic PPAR γ ligands on
the phagocytic capacity of FARM
(ii)The effect of the PPAR γ ligands on
proinflammatory cytokine production by assessing
TNF-α secretion in lipopolysaccharide activated
FARM.
Methods
Pulmonary lavage of the avian respiratory system
All experimental procedures were approved by the Ken-
yatta University Animal Ethics Committee. FARM were
obtained from the respiratory system of mature speci-
mens of domestic fowl as previously described [26].
Briefly, chickens were anesthetized and then euthanized
by intravenous injection of an overdose of pentobarbit-
one sodium (Euthanase®) into the brachial vein. The tra-
chea was then exposed and sterile pre-warmed (40 °C)
phosphate buffered saline (PBS) was poured down the
respiratory system. Recovered lavage fluid was centrifuged
and the pelleted FARM re-suspended in sterile cell-
culture medium.
Processing of FARM for transmission electron microscopy
(TEM)
Recovered FARM were fixed in 2.5 % phosphate buffered
glutaraldehyde solution for 12 h. The cells were then
post fixed in 1 % osmium tetraoxide in 0.1 M sodium
cacodylate buffer followed by dehydration in graded re-
placement of ethanol (70 %, 80 %, 90 %, and 100 %
twice). Gradual replacement of ethanol with propyleneoxide was then done before infiltrating and embedding
the cells in epoxy resin. Using Reichter® ultra-microtome,
semithin and ultrathin sections were obtained from proc-
essed blocks. The semithin sections were collected on
glass slides and stained with 3 % toluidine blue while the
ultrathin sections were picked on copper grids, stained
with uranyl acetate and lead citrate, and observed with a
Philips 201C TEM under an accelerating voltage of 60 Kv.
Micrographs were developed from the processed sections
for morphological studies.
In vitro viability of the FARM
FARM were washed three times in PBS and re-suspended
at a concentration of 1.5 × 105 cells/ml in sterile eppendorf
tubes containing RPMI-1640 cell culture medium and
treated with 9 μM of troglitazone (Abcam, Science
Park Cambridge, UK) for 1 h. A control pellet of FARM
was processed in a similar manner but without trogli-
tazone. The tubes were kept for 4 h in an incubator
(40 °C and 5 % CO2). A viable count of FARM was
assessed using trypan blue in hemocytometer.
Phagocytosis assays
Recovered FARM were re-suspended at concentrations
of 1.5 × 105 cells/ml in fresh RPMI - 1640 in sterile
eppendorf tubes. The FARM were treated with 9 μM of
troglitazone in incubator for 1 h. Treated and untreated
A B
Fig. 2 a Photomicrograph (×400) and (b) electron micrograph (×950) of FARM recovered by lavage of the chicken respiratory system. The cells
have eccentric nucleus (N) and plasma membrane ruffled with filopodial extensions (arrows). In (b), numerous cytoplasmic vesicular bodies
presumed to be lysosomes (red arrows) were identified. The Semithin (1 μm) and the ultrathin (80 nm) sections were cut from processed blocks

























Fig. 3 Under similar experimental conditions, there was no significant
(p≥ 0.05) difference in the in vitro viability of troglitazone treated and
untreated FARM. The bars show SEM
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(Sigma 3050 Spruce Street, USA) in incubator for 3 h.
Shaking of tubes was done regularly to ensure contact of
the cells and the particles. Thereafter, FARM were fixed
in 2.5 % phosphate buffered glutaraldehyde solution for
12 h and processed for TEM. Semithin and ultrathin
sections were processed for estimation of diameter of
the FARM and volume density of internalized particles
in the cells respectively.
Estimation of the diameters of the FARM and the volume
density of the phagocytized particles
Diameters of FARM were determined under an ocular
graticule with a linear scale at a magnification of × 100.
In each field, to avoid bias, only diameters of FARM at
the four corners of the fields were measured. The vol-
ume density of the phagocytized particles in the FARM
was estimated as previously described [27]. Briefly, ultra-
thin sections were processed and the corresponding mi-
crographs recorded on a 35-mm electron microscope
film prior to being projected onto a screen at a final
magnification of × 14 000. A quadratic lattice grid was
superimposed at a random position onto each projected
image. The total number of points falling onto profiles
of the phagocytized particles [P (p)] and on entire cell [P
(c)] was counted. Volume density of phagocytized parti-
cles [V V (p, c)] was then calculated as follows: V V
(p,c) = P (p) / P (c)
Measurement of TNF-α production by the FARM
The FARM were washed three times in PBS and seeded
at a density of 1.5 × 105 cells/well in RPMI 1640 with
5 % FCS into 24-well tissue culture. The cells were
treated with varying doses (3 μM, 6 μM and 9 μM) of
troglitazone for 1 h before addition of 0.1 ng/ml lipo-
polysaccharide (LPS). After 24 h incubation at 40 °C in
5 % CO2, the supernatants were harvested for TNF-αmeasurement using ELISA kit (Bicom Biotech, SA).
Briefly, the supernatants were diluted appropriately and
incubated with anti-chicken TNF-α antibody coated
plate at 40 °C for 1 h. The plate was washed 3 times in
phosphate buffered saline-tween (PBS-T) followed by
addition of biotin–streptavidin HRP labeled anti-chicken
TNF-α. The plate was incubated for 30 min at 40 °C
followed by 3 washes in PBS-T before addition of
chromogen.Data analysis
For paired experiments, student t–test was used to com-
pare the values on the chicken FARM in the various ex-
periments while analysis of group data for multiple
comparisons was performed using ANOVA followed by
Duncan’s multiple range test to determine the level of
differences. The level of significance was set at p ≤ 0.05
confidence level. The results were presented in form of
tables, graphs and micrographs. Means ± Standard Error
Table 1 Mean diameter of troglitazone treated and untreated
FARM


















Data represent the mean diameter of troglitazone treated and untreated
FARM that were co-cultured with polystyrene particles. The mean diameter of
treated FARM was not significantly (p ≥ 0.05) different from that of
untreated FARM




The lavage fluid recovered from the respiratory system
of the chicken contained both ciliated epithelial cells and
FARM (Fig. 1). Typically, the FARM had plasma mem-
brane ruffled with filopodial extensions and an eccen-
trically located nucleus (Fig. 2). Ultra structurally, the
FARM had variably electron dense vesicular cytoplasmic
organelles presumed to be lysosomes (Fig. 2b)A
Fig. 4 Photomicrographs showing internalized polystyrene based particles
treated FARM (b). The FARM and the particles were co-cultured in RPMI 16
semithin (1 μm) sections cut from processed blocks of epoxy resin embeddIn vitro viability of the FARM
Troglitazone treatment of chicken FARM at a dosage of
9 μM for 4 h did not compromise FARM viability. Tro-
glitazone treated FARM exhibited equivalent (p ≥ 0.05)
in vitro viability with untreated FARM under similar ex-
perimental conditions. The in vitro viability of troglita-
zone treated FARM and untreated FARM was 82 ± 1.5 %
and 83 ± 2.5 % respectively (Fig. 3).Morphometric observations
The mean diameter of troglitazone treated FARM was
not significantly (P ≥ 0.05) different from that of un-
treated FARM (Table 1). Quantitative estimation of load-
ing of FARM with polystyrene particles was assessed
using micrographs (Figs. 4 and 5). Despite having
equivalent diameters and therefore volume, the mean
volume density of internalized particles per unit volume
of treated FARM was 41 ± 1.0 %, a significant (P ≤ 0.05)
value compared to that of the untreated FARM which
was 21 ± 1.1 % (Fig. 6).The effect of troglitazone on TNF- α production by the
chicken FARM
To define the functional role of PPAR-γ in the chicken
FARM, the effect of troglitazone on cytokine production
by the chicken FARM was measured by determining
TNF-α concentrations in culture supernatants of
lipopolysaccharide-stimulated FARM after treatment
with graded (3 μM, 6 μM and 9 μM) doses of troglitazone.
Lipopolysaccharide elicited considerable amounts of TNF-
α production by FARM at concentration of 0.1 ng/ml.
Addition of troglitazone to cultures of LPS-induced
chicken FARM, significantly (p ≤ 0.05) inhibited TNF-α
production by the FARM in a dose dependent manner
(Fig. 7).B
(arrows) in (a) troglitazone untreated FARM and (b) troglitazone
40 culture medium for 3 h. The photomicrographs were prepared from
ed cell suspension. (×400)
A B
Fig. 5 Electron micrographs showing internalized polystyrene particles (arrows) in (a) troglitazone untreated and (b) troglitazone treated chciken
FARM. Three and twenty partciles have been phagocytozed in (a) and (b) respectively. In (b) the particles are engulfed in irregular vacoules
presumably an indication of enhanced destruction of internalized particles. The micropraphs were developed from ultrathin (80 nm) sections cut
from blocks of epoxy resin embedded cell suspension. (×950)
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In the present study, we examined the effect of PPAR γ
ligands on the phagocytic capacity of FARM. This study
reports for the first time that the phagocytic capacity of
freshly harvested chicken FARM is enhanced by selective
synthetic PPAR γ ligands. Selective synthetic PPAR γ
ligands improve the phagocytic ability of AM with sub-
sequent clearance of inflammatory site, an essential
process during restoration of alveolar architecture in the
mammalian lung [28]. Chronic inflammation, partly
characterized by accumulation of FARM with dimin-
ished phagocytic ability in the inflammatory site, causes
gross respiratory epithelial tissue destruction with subse-
quent high mortality in the poultry industry [29, 30].
Phagocytosis is the most important defense mechanism
in all phyla of the animal kingdom [31] and therefore,
up regulation of phagocytic ability of FARM by PPAR γ
agonists could be critical in clearance of inflammatory




































Fig. 6 Comparison of the mean volume density of internalized
particles in troglitazone treated FARM and in untreated chicken
FARM. Troglitazone treated FARM significantly (p≤ 0.05) internalized
more polystyrene particles than untreated FARM. Bars show SEMsubstantially improved the phagocytic ability FARM.
Further, troglitazone treated FARM had irregular vacu-
oles formed around ingested particles indicating up reg-
ulated destruction of internalized particles by the FARM.
A characteristic of non phlogistic phagocytosis is the
ability of activated macrophages to clear inflammatory
stimuli with diminished production of proinflammatory
cytokines [32]. To elucidate the non phlogistic functional
role of PPAR γ ligands during phagocytosis in the
FARM, we treated lipopolysaccharide activated FARM
with varying doses of troglitazone. Troglitazone treated
FARM inhibited TNF-α production in lipopolysaccharide
activated FARM in a dose dependent manner. TNF-α has
been reported as the primary regulator of inflammation
[33] and activated FARM produce TNF-α in response to
respiratory inflictions [34]. However, incessant production
of proinflammatory cytokines prolongs inflammation con-
tributing to pathogenesis of respiratory disease conditions
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Fig. 7 Comparison of TNF-α production by LPS-activated chicken
FARM treated with varying doses of troglitazone. Treatment of FARM
with increasing doses of troglitazone significantly (p≤ 0.05) inhibited
TNF-α production by the FARM. The bars show SEM
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tory responses may permit development of products for
the enhancement productivity in the poultry industry.
FARM are the predominant immune cells in the avian
lung [36] therefore, synthetic PPAR γ agonists could be
used in attenuating proinflammatory cytokine production
by the cells as a therapeutic intervention in resolving re-
spiratory inflammatory disease conditions in the poultry
industry.
Conclusion
In this study, selective synthetic PPAR γ agonists signifi-
cantly enhanced the phagocytic index of chicken FARM.
Further, the PPAR γ ligands attenuated production of
proinflammatory cytokine TNF-α by activated FARM.
This study, therefore, concludes that PPAR γ ligands are
attractive therapeutic novel drug targets for resolution of
avian respiratory inflammatory disease conditions.
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